“New strategies with 90Y-ibritumomab tiuxetan in diffuse large B-cell lymphoma and mantle cell lymphoma”, Hematol Meeting Rep, vol. 1, no. 5, Jun. 2009, doi: 10.4081/hmr.v1i5.644.